Detalhe da pesquisa
1.
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.
Br J Cancer
; 99(8): 1239-45, 2008 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18797458
2.
Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours.
Cancer Chemother Pharmacol
; 71(3): 647-56, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23299791
3.
Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.
Cancer Chemother Pharmacol
; 69(6): 1467-75, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382883